As speculation continues to swirl around AI’s forthcoming transformation of healthcare, fueling boom times in AI research, a review of the literature has turned up scant evidence the technology is benefiting patients at the consumer level.

Advances in diabetes care over the past decade haven’t translated into better patient outcomes, researchers at Massachusetts General Hospital have found, with just one in four U.S. adults with the disease meeting treatment goals between 2005 and 2016.

A team of researchers backed by a division within the National Institutes of Health (NIH) has created a novel MRI technique that can image a thinking brain 60-times faster than traditional methods.

CMS is planning to add a star ratings system to insurance plans offered through the individual exchange created from the Affordable Care Act, the agency announced August 15. The new ratings will be displayed for the 2020 open enrollment period on Healthcare.gov.

Demand for pediatric radiologists is currently outpacing the supply, according to a new analysis published in the Journal of the American College of Radiology. What could this trend mean going forward?

VR is quickly becoming a new alternative to more traditional methods of pain management, NPR reported, with patients escaping their chronic pain by strapping on a VR headset and becoming immersed in a different reality.

DeepMind Technologies Ltd., the Google/Alphabet-owned elephant in the AI research room, has lost more than $1 billion over the past three years. And it owes another billion to creditors who’ll be looking for their money back, with interest, over the next year or so.

“Silent” strokes are more common than overt strokes in older patients undergoing elective non-cardiac surgery, investigators with the NeuroVISION study have found.

The United States published more AI-based radiology studies than any other country across the globe, according to a new analysis released Aug. 15 in the American Journal of Roentgenology.

Making the switch from analog insulin to older types of the drug can save patients money, INSIDER reports—but it can also be dangerous.